Eppendorf electrodes |
C3H mammary tumors: significant difference in local tumor control between the fraction of hypoxic values (<2.5 mmHg) and less hypoxic tumors |
(36) |
Prostate cancer study (n = 57): 8-year survival is 78% for moderately hypoxic tumors and 46% for severe hypoxic tumors |
(16) |
n.a. |
|
|
|
|
|
Head and neck cancer study (n = 35): 2-year locoregional control is two times lower for hypoxic tumors (i.e., with 15% of readings <2.5 mmHg) |
(15) |
|
|
|
PET 18F-MISO |
FaDu hSCC xenografts: prognostic value of pretreatment 18F-MISO hypoxic volume; SUVmax was not associated with local control |
(25) |
5 head and neck studies (n = 45; 73; 12; 17; 15) |
(21, 24, 26, 27, 29) |
Mixed results |
(23) |
|
Lack of correlation with Eppendorf measurements in head and neck tumors |
|
PET 18F-FAZA |
Rhabdomyosarcoma: lower uptake linked to better local tumor control at 90 days post-irradiation |
(36) |
Head and neck cancer study: DAHANCA trial (n = 40), high tumor uptake is correlated to lower disease-free survival |
(38) |
Positive results |
(38) |
Validated with EPR oximetry in the preclinical setting (rat rhabdomyosarcomas) |
|
|
9L glioma and rhabdomyosarcoma: significant correlation between 18F-FAZA T/B and tumor growth delay |
(37) |
|
|
|
|
|
PET 18F-FETNIM |
|
|
1 head and neck cancer study (n = 21) |
(21) |
NO (but compared with other nitroimidazoles) |
(44, 45) |
2 lung cancer studies (n = 26; 32) |
|
1 cervical cancer study (n = 16) |
|
1 esophageal cancer study (n = 28) |
|
High fractional hypoxic volumes, uptake, or baseline SUVmax correlated with PFS, OS, or clinical response |
|
|
PET 60CU-ATSM |
Canine sinonasal tumors: lack of correlation between Cu-ATSM uptake and outcome |
(51) |
3 cervical cancer studies (n = 14; 15; 38) |
(21, 48–50) |
Mixed results |
(40, 57–63) |
2 head and neck cancer studies (n = 15; 11) |
Comparison with F-MISO, EF5, or pimonidazole: no link with hypoxia in different tumor models or in response to hyperoxic challenges
Comparison with Eppendorf electrodes: correlation with hypoxia in FaDu tumors but not in HT29 tumors
|
3 lung cancer studies (n = 19; 22; 7) |
Potential link with tumor redox status |
1 rectal cancer study (n = 19) |
|
|
|
|
Dynamic contrast-enhanced magnetic resonance imaging |
Melanoma xenografts: low ktrans is correlated with increased radioresistance |
(78) |
Cervical cancer study: ktrans and ABrix parameters correlated with poor outcome |
(80) |
Mixed results |
(82) |
|
|
|
Cervical cancer xenografts: basal ktrans correlated to the outcome of RT; skewness (heterogeneity) in ktrans distribution correlated with poorer outcome |
(79) |
|
|
Comparison with pimonidazole
Correlation between “poor perfusion” parameters and hypoxia (pimonidazole staining) in head and neck cancer patients
Lack of correlation in glioma mice xenografts and glioma patients
|
(83, 84) |
|
|
Mouse fibrosarcoma: none of the tested DCE parameters (ktrans, vp, Kep, % of perfused voxels) were related to RT outcome |
(69) |
|
|
|
|
|
|
G3H prolactinomas (rats) |
(100) |
Cervical cancer study: basal was predictive for RT response |
90 |
Mixed results |
(96–98) |
RIF-1 fibrosarcomas (mice) |
Lack of quantitative relationship between fluorescence quenching fiber optic probes pO2 values and values
Correlation between pimonidazole and high in prostate cancer
Inverse correlation between pimonidazole and in mammary tumors
|
was predictive for a transient reduction in tumor size; low baseline was linked to a small reduction in tumor size |
|
R1–T1 of water protons |
Dunning R3327-AT1 rat prostate |
(92) |
|
|
Mixed results |
|
A large increase in R1 response to hyperoxic challenge was linked to a longer tumor growth delay after radiation therapy |
No study addressing potential correlations between R1–T1 and quantitative pO2 measurements |
|
R1–T1 of lipid protons |
9L glioma |
(101) |
|
|
Mixed results |
(101, 123) |
Water and lipids T1 are less predictive of RT outcome than in this model |
Comparison with EPR oximetry
Positive correlation in mammary tumors
Lack of correlation in rat rhabdomyosarcoma and 9L glioma
|
|
Combined R1 and MRI |
Dunning rat prostate tumors |
(121) |
|
|
|
|
Useful factors to predict tumor response to hypofractionation |
|
EPR oximetry |
C6 and 9L glioma |
(151) |
|
|
|
|
pO2 assessed after a first course of RT was a prognostic indicator of differential response to RT between the two glioma models |
|
|
TLT and FSaII syngeneic tumors |
(69, 76, 130, 132, 136–146, 148) |
|
|
|
|
pO2 assessed during/after administration of treatments able to alleviate tumor oxygenation was predictive of the outcome of RT when administered during this window of reoxygenation |